Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Celltrion Healthcare Co stock

091990.KQ
KR7091990002

Price

0
Today +/-
-0
Today %
-0 %

Celltrion Healthcare Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Celltrion Healthcare Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Celltrion Healthcare Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Celltrion Healthcare Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Celltrion Healthcare Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Celltrion Healthcare Co Stock Price History

DateCelltrion Healthcare Co Price
1/12/20240 undefined
1/11/20240 undefined

Celltrion Healthcare Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Celltrion Healthcare Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Celltrion Healthcare Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Celltrion Healthcare Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Celltrion Healthcare Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Celltrion Healthcare Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Celltrion Healthcare Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Celltrion Healthcare Co’s growth potential.

Celltrion Healthcare Co Revenue, EBIT and net profit per share

DateCelltrion Healthcare Co RevenueCelltrion Healthcare Co EBITCelltrion Healthcare Co Net Income
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
2024e0 undefined0 undefined0 undefined
2023e0 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined

Celltrion Healthcare Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2014201520162017201820192020202120222023e2024e2025e2026e
0000000000000
-------------
-------------
0000000000000
0000000000000
-------------
0000000000000
-------------
Details

Keystats

ⓘ

Revenue and Growth

The Celltrion Healthcare Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Celltrion Healthcare Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201420152016201720182019202020212022
                 
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
                 
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Celltrion Healthcare Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Celltrion Healthcare Co's financial health and stability.

Assets

Celltrion Healthcare Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Celltrion Healthcare Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Celltrion Healthcare Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Celltrion Healthcare Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201420152016201720182019202020212022
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
000000000
---------
000000000
000000000
000000000
000000000

Celltrion Healthcare Co stock margins

The Celltrion Healthcare Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Celltrion Healthcare Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Celltrion Healthcare Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Celltrion Healthcare Co's sales revenue. A higher gross margin percentage indicates that the Celltrion Healthcare Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Celltrion Healthcare Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Celltrion Healthcare Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Celltrion Healthcare Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Celltrion Healthcare Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Celltrion Healthcare Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Celltrion Healthcare Co Margin History

Celltrion Healthcare Co Gross marginCelltrion Healthcare Co Profit marginCelltrion Healthcare Co EBIT marginCelltrion Healthcare Co Profit margin
2026e0 %0 %0 %
2025e0 %0 %0 %
2024e0 %0 %0 %
2023e0 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %

Celltrion Healthcare Co Stock Sales Revenue, EBIT, Earnings per Share

The Celltrion Healthcare Co earnings per share therefore indicates how much revenue Celltrion Healthcare Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Celltrion Healthcare Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Celltrion Healthcare Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Celltrion Healthcare Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Celltrion Healthcare Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Celltrion Healthcare Co Revenue, EBIT and net profit per share

DateCelltrion Healthcare Co Sales per ShareCelltrion Healthcare Co EBIT per shareCelltrion Healthcare Co Earnings per Share
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
2024e0 undefined0 undefined0 undefined
2023e0 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined

Celltrion Healthcare Co business model

Celltrion Healthcare Co Ltd is a leading South Korean biopharmaceutical company that focuses on the development and manufacturing of biological drugs for the treatment of severe and complex diseases. The company was founded in 2009 and is headquartered in Incheon, South Korea. Celltrion Healthcare Co is one of the most popular companies on Eulerpool.com.

Celltrion Healthcare Co SWOT Analysis

Strengths

Celltrion Healthcare Co Ltd has several strengths that provide a competitive advantage in the pharmaceutical industry. These strengths include:

  • Strong product portfolio: Celltrion Healthcare Co Ltd offers a wide range of innovative and high-quality pharmaceutical products, contributing to its market leadership position.
  • Advanced research and development capabilities: The company invests significantly in research and development, allowing it to introduce new and effective products to the market.
  • Strong global presence: Celltrion Healthcare Co Ltd has established a strong international presence, expanding its reach and market share in various regions.
  • Strong financial position: The company boasts a healthy financial position, enabling it to invest in strategic initiatives and acquisitions for future growth.

Weaknesses

Despite its strengths, Celltrion Healthcare Co Ltd also faces certain weaknesses that could hinder its growth and competitive positioning. These weaknesses include:

  • Dependency on limited product offerings: The company's revenue heavily relies on a few key products, exposing it to potential market fluctuations and competition.
  • Regulatory challenges: Operating in the pharmaceutical industry involves navigating complex and evolving regulatory frameworks, which could pose challenges for Celltrion Healthcare Co Ltd.
  • Relatively smaller market share in some regions: Celltrion Healthcare Co Ltd faces strong competition in certain regions, making it challenging to increase its market share.

Opportunities

To capitalize on its strengths and overcome weaknesses, Celltrion Healthcare Co Ltd should consider the following opportunities:

  • Expansion into emerging markets: The company can explore expansion opportunities in growing healthcare markets, such as Asia and Latin America, to diversify its revenue streams.
  • Focus on product innovation: Continued investment in research and development can lead to the development of breakthrough drugs, expanding the company's product portfolio.
  • Strategic collaborations and partnerships: Celltrion Healthcare Co Ltd can establish strategic alliances with other companies or research institutions to jointly develop and commercialize new products.

Threats

Celltrion Healthcare Co Ltd must also be wary of potential threats that could impact its growth prospects and competitive position:

  • Intense competition: The pharmaceutical industry is highly competitive, and the company faces competition from both established and emerging players.
  • Patent expirations: The expiration of patents for key products can result in increased competition from generic manufacturers, leading to decreased market share and revenue.
  • Compliance with regulations: Changes in regulatory requirements can increase compliance costs and potentially delay product approvals, affecting the company's ability to launch new products.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Celltrion Healthcare Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Celltrion Healthcare Co historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Celltrion Healthcare Co shares outstanding

The number of shares was Celltrion Healthcare Co in 2023 — This indicates how many shares 155.05 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Celltrion Healthcare Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Celltrion Healthcare Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Celltrion Healthcare Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Celltrion Healthcare Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Celltrion Healthcare Co stock splits

In Celltrion Healthcare Co's history, there have been no stock splits.
Celltrion Healthcare Co does not pay out any dividends.
Celltrion Healthcare Co does not pay out any dividends.
Celltrion Healthcare Co does not pay out any dividends.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Celltrion Healthcare Co.

Celltrion Healthcare Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20230 0  (-28.27 %)2023 Q3
6/30/20230 0  (-60.63 %)2023 Q2
3/31/20230 0  (13.77 %)2023 Q1
12/31/20220 0  (-206.13 %)2022 Q4
9/30/20220 0  (103.09 %)2022 Q3
6/30/20220 0  (-9.15 %)2022 Q2
3/31/20220 0  (26 %)2022 Q1
12/31/20210 0  (-76.37 %)2021 Q4
9/30/20210 0  (-54.82 %)2021 Q3
6/30/20210 0  (-24.59 %)2021 Q2
1
2
3

Eulerpool ESG Scorecard© for the Celltrion Healthcare Co stock

Eulerpool World ESG Rating (EESG©)

48/ 100

🌱 Environment

52

👫 Social

49

🏛️ Governance

42

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Celltrion Healthcare Co shareholders

%
Name
Stocks
Change
Date
24.28966 % Celltrion Healthcare Holdings Co.,Ltd.39,946,77006/30/2023
11.19103 % Seo (Jeong Jin)18,404,77006/30/2023
1.71576 % The Vanguard Group, Inc.2,821,746-4,2039/30/2023
1.35601 % BlackRock Institutional Trust Company, N.A.2,230,094-5,9519/30/2023
1.35308 % Celltrion Skincure Co., Ltd.2,225,28306/30/2023
0.96146 % Norges Bank Investment Management (NBIM)1,581,211504,71512/31/2022
0.68830 % Samsung Asset Management Co., Ltd.1,131,976489/30/2023
0.58745 % BlackRock Advisors (UK) Limited966,12725,4089/30/2023
0.39474 % Mirae Asset Global Investments Co., Ltd.649,188-32,1608/31/2023
0.27122 % Geode Capital Management, L.L.C.446,0563,5028/31/2023
1
2
3
4
5
...
10

Celltrion Healthcare Co Executives and Management Board

Mr. Hyeong Gi Kim

(56)
Celltrion Healthcare Co Chief Executive Officer, Vice Chairman of the Board (since 2019)
Compensation 1.51 B

Mr. Jun Seok Seo

(35)
Celltrion Healthcare Co Director
Compensation 1.31 B

Mr. Han Gi Lee

(44)
Celltrion Healthcare Co Chief Financial Officer, Assistant Managing Director (since 2019)

Mr. Yik Seong Ahn

(49)
Celltrion Healthcare Co Managing Director (since 2019)

Mr. Ho Wung Kim

(49)
Celltrion Healthcare Co Managing Director (since 2019)
1
2
3

Celltrion Healthcare Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Orion B Stock
Orion B
SupplierCustomer0,770,610,48-0,20-0,40-0,11
Teva Pharmaceutical Inds Stock
Teva Pharmaceutical Inds
SupplierCustomer0,740,52-0,25-0,260,520,58
Perrigo Stock
Perrigo
SupplierCustomer0,68-0,460,200,160,760,46
Hikma Pharmaceuticals Stock
Hikma Pharmaceuticals
SupplierCustomer0,490,740,490,650,870,65
Kerry Logistics Network Stock
Kerry Logistics Network
SupplierCustomer0,440,340,390,75-0,34-0,40
UDG Healthcare PLC Stock
UDG Healthcare PLC
SupplierCustomer0,20-0,56-0,63-0,58-0,73
Adcock Ingram Stock
Adcock Ingram
SupplierCustomer0,110,790,600,78
Walgreens Boots Alliance Stock
Walgreens Boots Alliance
SupplierCustomer-0,070,300,530,070,26-0,16
Pfizer Stock
Pfizer
SupplierCustomer-0,240,70-0,140,01-0,79-0,70
Boditech Med Stock
Boditech Med
SupplierCustomer-0,280,770,600,450,830,37
1

Most common questions regarding Celltrion Healthcare Co

What values and corporate philosophy does Celltrion Healthcare Co represent?

Celltrion Healthcare Co Ltd represents values of innovation, dedication, and patient-centricity. As a leading global biopharmaceutical company, Celltrion Healthcare is committed to developing and providing affordable, high-quality biopharmaceutical products for patients across the world. Their corporate philosophy revolves around improving global healthcare by harnessing the power of advanced biotechnology. Through extensive research and development, Celltrion Healthcare aims to address unmet medical needs and contribute to the well-being of individuals. With their strong focus on innovation and patient well-being, Celltrion Healthcare remains dedicated to the advancement of healthcare globally.

In which countries and regions is Celltrion Healthcare Co primarily present?

Celltrion Healthcare Co Ltd primarily operates in various countries and regions globally. The company has a significant presence in South Korea, where it is headquartered. Additionally, Celltrion Healthcare has expanded its operations in various international markets, including the United States, Europe, Asia Pacific, and Latin America. With its strong international footprint, Celltrion Healthcare Co Ltd strives to provide innovative healthcare solutions and enhance access to advanced treatments for patients across different regions and markets.

What significant milestones has the company Celltrion Healthcare Co achieved?

Celltrion Healthcare Co Ltd has achieved significant milestones in its history. The company has been successful in developing and commercializing innovative biosimilar products, contributing to improved access to affordable biologics for patients worldwide. Additionally, Celltrion Healthcare Co Ltd has received regulatory approvals for various biosimilars, including those for autoimmune diseases and oncology. Moreover, the company has expanded its global presence by establishing partnerships and collaborations with leading pharmaceutical companies. These achievements highlight Celltrion Healthcare Co Ltd's commitment to advancing healthcare through the development of high-quality biosimilars and innovative treatments for patients across the globe.

What is the history and background of the company Celltrion Healthcare Co?

Celltrion Healthcare Co Ltd is a global biopharmaceutical company that specializes in the development and distribution of innovative and biosimilar therapeutics. Founded in 2002, the company has made substantial advancements in the healthcare industry. Celltrion Healthcare focuses on the research and production of high-quality drugs to provide affordable treatment options for patients worldwide. With a strong commitment to research and development, the company has successfully launched multiple biosimilar products, catering to various therapeutic areas. Celltrion Healthcare Co Ltd continues to excel in its mission to improve healthcare accessibility and enhance patients' quality of life through innovative medical solutions.

Who are the main competitors of Celltrion Healthcare Co in the market?

The main competitors of Celltrion Healthcare Co Ltd in the market are multinational pharmaceutical companies such as Roche, Novartis, and Johnson & Johnson.

In which industries is Celltrion Healthcare Co primarily active?

Celltrion Healthcare Co Ltd is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of Celltrion Healthcare Co?

The business model of Celltrion Healthcare Co Ltd is focused on the development, manufacturing, and commercialization of biopharmaceutical products. As a leading biopharmaceutical company, Celltrion Healthcare specializes in the production of biosimilar drugs, which are cost-effective alternatives to existing biologic medications. By leveraging its expertise in biotechnology, Celltrion Healthcare aims to provide affordable and accessible treatments for patients worldwide. Through strategic partnerships and continuous research and development, the company aims to expand its product portfolio and enhance patient care in various therapeutic areas.

What is the P/E ratio of Celltrion Healthcare Co 2024?

The P/E ratio cannot be calculated for Celltrion Healthcare Co at the moment.

What is the P/S ratio of Celltrion Healthcare Co 2024?

The P/S cannot be calculated for Celltrion Healthcare Co currently.

What is the Quality Investing of Celltrion Healthcare Co?

The Quality Investing for Celltrion Healthcare Co is 4/10.

What is the revenue of Celltrion Healthcare Co 2024?

The revenue cannot currently be calculated for Celltrion Healthcare Co.

How high is the profit of Celltrion Healthcare Co 2024?

The profit cannot currently be calculated for Celltrion Healthcare Co.

What is the business model of Celltrion Healthcare Co

Celltrion Healthcare Co Ltd is a South Korean company specialized in the development, manufacturing, and marketing of biological products and drugs for various diseases and conditions.

What is the Celltrion Healthcare Co dividend?

Celltrion Healthcare Co pays a dividend of 0 KRW distributed over payouts per year.

How often does Celltrion Healthcare Co pay dividends?

The dividend cannot currently be calculated for Celltrion Healthcare Co or the company does not pay out a dividend.

What is the Celltrion Healthcare Co ISIN?

The ISIN of Celltrion Healthcare Co is KR7091990002.

What is the Celltrion Healthcare Co ticker?

The ticker of Celltrion Healthcare Co is 091990.KQ.

How much dividend does Celltrion Healthcare Co pay?

Over the past 12 months, Celltrion Healthcare Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Celltrion Healthcare Co is expected to pay a dividend of 132.37 KRW.

What is the dividend yield of Celltrion Healthcare Co?

The current dividend yield of Celltrion Healthcare Co is .

When does Celltrion Healthcare Co pay dividends?

Celltrion Healthcare Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Celltrion Healthcare Co?

Celltrion Healthcare Co paid dividends every year for the past 6 years.

What is the dividend of Celltrion Healthcare Co?

For the upcoming 12 months, dividends amounting to 132.37 KRW are expected. This corresponds to a dividend yield of 0.17 %.

In which sector is Celltrion Healthcare Co located?

Celltrion Healthcare Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Celltrion Healthcare Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Celltrion Healthcare Co from 3/1/2023 amounting to 125 KRW, you needed to have the stock in your portfolio before the ex-date on 12/28/2022.

When did Celltrion Healthcare Co pay the last dividend?

The last dividend was paid out on 3/1/2023.

What was the dividend of Celltrion Healthcare Co in the year 2023?

In the year 2023, Celltrion Healthcare Co distributed 125 KRW as dividends.

In which currency does Celltrion Healthcare Co pay out the dividend?

The dividends of Celltrion Healthcare Co are distributed in KRW.

All fundamentals about Celltrion Healthcare Co

Our stock analysis for Celltrion Healthcare Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Celltrion Healthcare Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.